Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer.

Renaud S, Guerrera F, Seitlinger J, Reeb J, Voegeli AC, Legrain M, Mennecier B, Santelmo N, Falcoz PE, Quoix E, Chenard MP, Weingertner N, Beau-Faller M, Massard G.

Clin Lung Cancer. 2018 Nov;19(6):e919-e931. doi: 10.1016/j.cllc.2018.08.005. Epub 2018 Aug 22.

PMID:
30217639
2.

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients.

Emprou C, Le Van Quyen P, Jégu J, Prim N, Weingertner N, Guérin E, Pencreach E, Legrain M, Voegeli AC, Leduc C, Mennecier B, Falcoz PE, Olland A, Santelmo N, Quoix E, Massard G, Guenot D, Chenard MP, Beau-Faller M.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1545. [Epub ahead of print]

3.

Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.

Renaud S, Seitlinger J, Guerrera F, Reeb J, Beau-Faller M, Voegeli AC, Siat J, Clément-Duchêne C, Tiotiu A, Santelmo N, Costardi L, Ruffini E, Falcoz PE, Vignaud JM, Massard G.

Ann Surg Oncol. 2018 Apr;25(4):1069-1078. doi: 10.1245/s10434-018-6347-3. Epub 2018 Jan 23.

PMID:
29362963
4.

Biological pathways underlying the association of red cell distribution width and adverse clinical outcome: Results of a prospective cohort study.

Zurauskaite G, Meier M, Voegeli A, Koch D, Haubitz S, Kutz A, Bernasconi L, Huber A, Bargetzi M, Mueller B, Schuetz P.

PLoS One. 2018 Jan 17;13(1):e0191280. doi: 10.1371/journal.pone.0191280. eCollection 2018.

5.

The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.

Zurfluh S, Baumgartner T, Meier MA, Ottiger M, Voegeli A, Bernasconi L, Neyer P, Mueller B, Schuetz P.

Expert Rev Anti Infect Ther. 2018 Feb;16(2):133-142. doi: 10.1080/14787210.2018.1426460. Epub 2018 Jan 17. Review.

PMID:
29316826
6.

A compound heterozygote case of isolated sulfite oxidase deficiency.

Brumaru D, Guerin E, Voegeli AC, Eyer D, Maitre M.

Mol Genet Metab Rep. 2017 Jul 6;12:99-102. doi: 10.1016/j.ymgmr.2017.06.009. eCollection 2017 Sep.

7.

Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.

Renaud S, Schaeffer M, Falcoz PE, Seitlinger J, Romain B, Voegeli AC, Legrain M, Reeb J, Santelmo N, Rohr S, Brigand C, Olland A, Guenot D, Massard G.

Eur J Cardiothorac Surg. 2017 Feb 1;51(2):255-262. doi: 10.1093/ejcts/ezw304.

PMID:
28186237
8.

Clinical and radiological outcomes after distal oblique osteotomy for the treatment of stage II hallux rigidus: Mid-term results.

Voegeli AV, Marcellini L, Sodano L, Perice RV.

Foot Ankle Surg. 2017 Mar;23(1):21-26. doi: 10.1016/j.fas.2015.12.004. Epub 2015 Dec 21.

PMID:
28159038
9.

Epidermal growth factor receptor and v-Ki-ras2 Kirsten rat sarcoma viral oncogen homologue-specific amino acid substitutions are associated with different histopathological prognostic factors in resected non-small-cell lung cancer.

Seitlinger J, Renaud S, Falcoz PE, Schaeffer M, Olland A, Reeb J, Santelmo N, Legrain M, Voegeli AC, Weingertner N, Chenard MP, Beau-Faller M, Massard G.

Interact Cardiovasc Thorac Surg. 2016 Dec;23(6):902-907. Epub 2016 Aug 15.

PMID:
27530493
10.

Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.

Renaud S, Seitlinger J, Falcoz PE, Schaeffer M, Voegeli AC, Legrain M, Beau-Faller M, Massard G.

Br J Cancer. 2016 Jul 26;115(3):346-53. doi: 10.1038/bjc.2016.182. Epub 2016 Jun 23.

11.

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.

Italiano A, Di Mauro I, Rapp J, Pierron G, Auger N, Alberti L, Chibon F, Escande F, Voegeli AC, Ghnassia JP, Keslair F, Laé M, Ranchère-Vince D, Terrier P, Baffert S, Coindre JM, Pedeutour F.

Lancet Oncol. 2016 Apr;17(4):532-538. doi: 10.1016/S1470-2045(15)00583-5. Epub 2016 Mar 10.

PMID:
26970672
12.

Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.

Guerrera F, Renaud S, Tabbó F, Voegeli' AC, Filosso PL, Legrain M, Boita M, Schaeffer M, Beau-Faller M, Ruffini E, Falcoz PE, Inghirami G, Oliaro A, Massard G.

Eur J Cardiothorac Surg. 2017 Apr 1;51(4):680-688. doi: 10.1093/ejcts/ezw362.

PMID:
28329143
13.

Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer.

Renaud S, Schaeffer M, Voegeli AC, Legrain M, Guérin E, Meyer N, Mennecier B, Quoix E, Falcoz PE, Guénot D, Massard G, Noël G, Beau-Faller M.

Future Oncol. 2016 Jan;12(1):59-70. doi: 10.2217/fon.15.273. Epub 2015 Nov 30.

PMID:
26616848
14.

Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases.

Renaud S, Falcoz PE, Schaëffer M, Guenot D, Romain B, Olland A, Reeb J, Santelmo N, Chenard MP, Legrain M, Voegeli AC, Beau-Faller M, Massard G.

Br J Cancer. 2015 Oct 20;113(8):1206-15. doi: 10.1038/bjc.2015.327. Epub 2015 Sep 15.

15.

Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification.

Weingertner N, Meyer N, Voegeli AC, Guenot D, Renaud S, Massard G, Falcoz PE, Olland A, Mennecier B, Gaub MP, Lindner V, Ghnassia JP, Quoix E, Chenard MP, Beau-Faller M.

Pathology. 2015 Jun;47(4):320-8. doi: 10.1097/PAT.0000000000000269.

PMID:
25938344
16.

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients.

Prim N, Legrain M, Guerin E, Mennecier B, Weingertner N, Voegeli AC, Guenot D, Maugard CM, Quoix AE, Beau-Faller M.

Eur Respir Rev. 2014 Sep;23(133):390-2. doi: 10.1183/09059180.00009313. No abstract available.

17.

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.

Beau-Faller M, Prim N, Ruppert AM, Nanni-Metéllus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Crémoux P, Solassol J, de Fraipont F, Bièche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J.

Ann Oncol. 2014 Jan;25(1):126-31. doi: 10.1093/annonc/mdt418. Epub 2013 Nov 26.

18.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.

J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.

PMID:
24183959
19.

[Comparative cost analysis of molecular biology methods in the diagnosis of sarcomas].

Baffert S, Italiano A, Pierron G, Traoré MA, Rapp J, Escande F, Ghnassia JP, Terrier P, Voegeli AC, Ranchere-Vince D, Coindre JM, Pedeutour F.

Bull Cancer. 2013 Oct;100(10):963-71. doi: 10.1684/bdc.2013.1822. French.

PMID:
24095719
20.

A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis.

Kurtz JE, Asmane I, Voegeli AC, Neuville A, Dufresne A, Litique V, Chevreau C, Bergerat JP.

Sarcoma. 2010;2010:458156. doi: 10.1155/2010/458156. Epub 2010 Mar 17.

21.

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.

Beau-Faller M, Legrain M, Voegeli AC, Guérin E, Lavaux T, Ruppert AM, Neuville A, Massard G, Wihlm JM, Quoix E, Oudet P, Gaub MP.

Br J Cancer. 2009 Mar 24;100(6):985-92. doi: 10.1038/sj.bjc.6604925.

22.

Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.

Pencreach E, Guérin E, Nicolet C, Lelong-Rebel I, Voegeli AC, Oudet P, Larsen AK, Gaub MP, Guenot D.

Clin Cancer Res. 2009 Feb 15;15(4):1297-307. doi: 10.1158/1078-0432.CCR-08-0889. Epub 2009 Feb 3.

23.

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.

Ruppert AM, Beau-Faller M, Neuville A, Guerin E, Voegeli AC, Mennecier B, Legrain M, Molard A, Jeung MY, Gaub MP, Oudet P, Quoix E.

Eur Respir J. 2009 Feb;33(2):436-40. doi: 10.1183/09031936.00162307.

24.

Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Chamouard P, Monneaux F, Richert Z, Voegeli AC, Lavaux T, Gaub MP, Baumann R, Oudet P, Muller S.

Dig Dis Sci. 2009 Oct;54(10):2084-93. doi: 10.1007/s10620-008-0590-6. Epub 2008 Dec 3.

PMID:
19051021
25.

Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit.

Zhang D, Lavaux T, Voegeli AC, Lavigne T, Castelain V, Meyer N, Sapin R, Aunis D, Metz-Boutigue MH, Schneider F.

Clin Chem. 2008 Sep;54(9):1497-503. doi: 10.1373/clinchem.2007.102442. Epub 2008 Jul 17.

26.

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

Beau-Faller M, Ruppert AM, Voegeli AC, Neuville A, Meyer N, Guerin E, Legrain M, Mennecier B, Wihlm JM, Massard G, Quoix E, Oudet P, Gaub MP.

J Thorac Oncol. 2008 Apr;3(4):331-9. doi: 10.1097/JTO.0b013e318168d9d4.

27.

Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping.

Entz-Werle N, Schneider A, Kalifa C, Voegeli AC, Tabone MD, Marec-Berard P, Marcellin L, Pacquement H, Terrier P, Boutard P, Meyer N, Gaub MP, Lutz P, Babin A, Oudet P.

Br J Cancer. 2003 Jun 16;88(12):1925-31.

28.

Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia.

Guérin E, Entz-Werlé N, Eyer D, Pencreac'h E, Schneider A, Falkenrodt A, Uettwiller F, Babin A, Voegeli AC, Lessard M, Gaub MP, Lutz P, Oudet P.

Leukemia. 2003 Mar;17(3):532-40.

PMID:
12646941
29.

[Official medicine and homeopathy].

VOEGELI A.

Rev Med Suisse Romande. 1951 Oct;71(10):660-72. Undetermined Language. No abstract available.

PMID:
14912741
30.

[Dental caries].

VOEGELI A.

Rev Med Suisse Romande. 1950 May 25;70(5):269-81. Undetermined Language. No abstract available.

PMID:
15430796
31.

Une nouvelle maladie?

VOEGELI A.

Rev Med Suisse Romande. 1948 Nov 25;68(11):766-75. Undetermined Language. No abstract available.

PMID:
18099394

Supplemental Content

Loading ...
Support Center